Invictus RG’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Invictus RG’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-5,374	Closed	-$314K	–	754
2017 Q2	$314K	Buy	5,374 +2,873	+115%	+$149K	0.23%	171
2017 Q1	$115K	Buy	+2,501	New	+$124K	0.08%	424
2016 Q4	–	Sell	-2,939	Closed	-$131K	–	796
2016 Q3	$131K	Sell	2,939 -3,556	-55%	-$154K	0.1%	360
2016 Q2	$248K	Buy	6,495 +3,072	+90%	+$135K	0.26%	139
2016 Q1	$141K	Sell	3,423 -8,549	-71%	-$352K	0.17%	233
2015 Q4	$581K	Buy	+11,972	New	+$533K	0.56%	30

Other funds holding SYNH

THLTP

Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Invictus RG's SYNH Position: Q3 2017 in Review

Invictus RG sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2017, closing a stake of 5,374 shares — an estimated $314K sold.

Invictus RG first reported a position in SYNH in Q4 2015 and held it in 6 quarters. The position peaked at $581K in Q4 2015. 238 funds tracked by Wall St. Rank hold SYNH as of Q3 2017.

Invictus RG reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2017 after selling out during the quarter.
Invictus RG sold 5,374 Syneos Health, Inc. Class A Common Stock shares in Q3 2017, an estimated $314K.
Invictus RG first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2015 and held it in 6 quarters.
Invictus RG's Syneos Health, Inc. Class A Common Stock position peaked at $581K in Q4 2015.
238 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2017.

Based on Invictus RG's 13F filing for Q3 2017, filed 13 Nov 2017.